C ompromised skeletal strength is fundamental to the increased fracture risk seen in osteoporosis (1) . Bone mineral density (BMD) measured from dual-energy x-ray absorptiometry (DXA) is the most readily quantified measure of skeletal strength, and meta-analyses have confirmed that BMD predicts low-trauma fractures (2, 3) . Although areal BMD from DXA is widely used for fracture prediction, its accuracy is limited (3) . Paradoxically, most fractures occur in individuals with BMD above the osteoporotic threshold [i.e., a T-score 2.5 standard deviations (SDs) below the young adult mean], highlighting the need for better prediction tools (4) (5) (6) .
Despite the ability of areal BMD to predict incident fractures, DXA does not fully account for the size and structural characteristics of bone. It is well known that failure to adequately compensate for the unmeasured third dimension (depth) in the scans results in larger bones giving greater apparent areal BMD than smaller bones, even when bone mass per unit volume is identical. This effect has also been demonstrated to contribute to sexand race/ethnicity-related differences in BMD as measured by DXA (7) (8) (9) (10) . Even within a racially/ethnically homogeneous population of white women undergoing baseline DXA, those with smaller total hip bone area were more likely to be categorized as being osteoporotic than women with larger bone area, despite being younger and at lower fracture risk (11) .
In 2008, FRAX ® , a fracture risk assessment tool (Centre for Metabolic Bone Diseases, University of Sheffield, United Kingdom), was released for estimation of individualized 10-year probability of hip and major osteoporotic fracture (MOH; composite of hip, clinical spine, distal forearm, and proximal humerus) (12, 13) . The input variables were selected after a series of metaanalyses using data from nine prospective international population-based cohorts. In addition to age, sex, and body mass index, additional clinical risk factors for fractures include prior fragility fracture, parental history of hip fracture, prolonged use of glucocorticoids, rheumatoid arthritis, current cigarette smoking, alcohol intake of $3 units/d, and secondary osteoporosis and (optionally) femoral neck BMD.
Our primary hypothesis was that smaller skeletal size, as determined by total hip bone area from DXA, would overestimate fracture risk whereas larger bone size would underestimate fracture risk. Because longer hip axis length (HAL) is a height-, BMD-, and FRAX ® -independent risk factor for hip fracture and is positively correlated with skeletal size, we had a secondary hypothesis that HAL would mitigate the effect of skeletal size on FRAX ® prediction (14) (15) (16) . A large clinical cohort of white women with linkage to fracture outcomes in a population-based data repository was used to test these hypotheses.
Methods

Study population
We included all self-identified white women age 40 years and older registered for health coverage in the province of Manitoba (Canada) who underwent baseline bone density measurement of the proximal femur with a single fan-beam scanner configuration (Prodigy; GE Healthcare, Madison, WI). Self-reported ethnicity was recorded at the time of testing from a limited set of options (white, black, Asian, Hispanic, aboriginal, other), with only 3% self-reported nonwhite. For women with more than one eligible set of measurements, only the first record was included. In Manitoba, health services are provided to almost all residents and recorded through a single public health care system. Bone density testing with DXA has been managed as an integrated program since 1997 and uses targeted case-finding before age 65 years, with screening of woman after age 65 years (17) . The program maintains a database of all DXA results, which can be linked with other population-based computerized health databases through an anonymous personal identifier (18) . The DXA database has been previously described with completeness and accuracy in excess of 99%.
The University of Manitoba Health Research Ethics Board approved the study.
Bone density measurements
DXA scans were obtained and analyzed in accordance with manufacturer recommendations. Hip T-scores were calculated by using National Health and Nutrition Examination Survey III reference values for white women. All hip scans were then reprocessed by using a single unmodified commercial version of the software (enCore, version 14.x with Advanced Hip Assessment; GE Healthcare) to obtain total hip bone area (in centimeters squared) and HAL (in millimeters), defined as the distance from base of the greater trochanter to the inner pelvic rim.
The three DXA instruments used in the province were crosscalibrated by using anthropomorphic phantoms, and no clinically significant differences were identified (T-score differences ,0.1). Therefore, all analyses are based on the unadjusted numeric results provided by the instrument. No magnification effects have been reported with the densitometer used in this study (19, 20) . Densitometers showed stable long-term performance (coefficient of variation , 0.5%) and satisfactory in vivo precision (coefficient of variation, 2.3% for femoral neck BMD and 0.9% for HAL).
Fracture probability calculations
Ten-year probability of a hip fracture was calculated by using the Canadian FRAX ® tool (FRAX ® Desktop MultiPatient Entry, version 3.7). Briefly, prior fracture and other conditions required for calculating fracture probability with FRAX ® were assessed through a combination of hospital discharge abstracts [diagnoses and procedures coded by using the International Classification of Diseases (ICD), ninth revision, Clinical Modification, before 2004 and the 10th revision of ICD, Canadian version, thereafter] and physician billing claims (coded by using ICD, ninth revision, Clinical Modification) as previously described (21, 22) . Proxies were used for smoking (chronic obstructive pulmonary disease diagnosis) and high alcohol intake (alcohol or substance abuse diagnosis) over the same time frame; prevalences and weights of these surrogate variables have been shown to be similar to population-based data (23) (24) (25) . Prolonged corticosteroid use (more than 90 days dispensed in the year before to DXA testing) was obtained from the provincial pharmacy system (26) . Height and weight at the time of DXA testing were measured by using a wall-mounted stadiometer and floor scale, respectively. We also documented osteoporosis treatment use (bisphosphonates, calcitonin, systemic estrogen products, raloxifene, and teriparatide) over the same time frame. We adjusted for the effect of incomplete parental hip fracture information on fracture probability estimates prior to 2005 using age-and sex-specific adjustment factors derived from 2005 to 2008 parental hip fracture responses (24) . Predictions with the Canadian FRAX ® tool have been shown to agree closely with observed fracture rates in our cohort and in the general Canadian population (23, 24) .
Fracture outcomes
Hospital discharge abstracts and physician billing claims were assessed from date of DXA (index date) to the earliest of 31 March 2013 or 15 years for the presence of nontraumatic hip, clinical vertebral, forearm, and humerus fracture diagnosis codes [collectively designated "major osteoporotic" fractures (MOFs)] using previously validated algorithms (21) . Fractures not associated with trauma diagnosis codes were assessed through a combination of hospital discharge abstracts and physician billing claims. Hip and forearm fractures were required to have a site-specific fracture reduction, fixation, or casting codes to enhance specificity for an acute fracture event. To minimize potential misclassification of prior and incident fractures involving the same skeletal site, we required that there be no hospitalization or physician visit(s) with the same fracture type in the 12 months preceding an incident fracture diagnosis.
Statistical analysis
Independent sample t tests were used to compare baseline measures in women with incident fractures to the measures in women without fractures. The population was stratified into quintiles according to total hip bone area (quintile 1, smallest; quintile 5, largest). Baseline characteristics were estimated for women in each quintile, and the P value for the linear trend was computed. Crude incident MOF and hip fracture rates (per 1000 person-years) were estimated for women in each total hip area quintile, and the P value for linear trend was again computed. Cox proportional hazards regression models were constructed for time to incident MOF and time to incident hip fracture. Preliminary analyses showed that results were unaffected by adjustment for osteoporosis treatment, consistent with our previous report (27) ; therefore, this was excluded from the final parsimonious models. As a measure of discrimination, hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated for total hip bone area, expressed as both quintile category (referents: quintile 3 for primary analysis and quintile 1 for sensitivity analysis) and as a continuous measure (gradient of risk per SD increase in total hip bone area). HRs were initially adjusted for 10-year fracture probability with BMD (model 1), and then additionally for HAL (model 2). Fracture probability scores, which are skewed, were log-transformed to produce a more normal distribution. Based on analyses of the Schoenfeld residuals, we did not identify any violations of the proportional hazards assumptions.
To assess calibration, the cumulative incidence function for incident MOF and hip fracture probability to 10 years was constructed by following a competing mortality risk framework (28) . Observed fracture probability was compared with expected probability predicted by fracture probability calculated without and with BMD. This calibration ratio of observed to predicted fracture probability should approximate unity for a well-calibrated tool. Ratios significantly less than unity imply risk overestimation (fewer events than predicted), whereas ratios significantly greater than unity imply risk underestimation (more events than expected). A priori, we defined clinically important "miscalibration" as a $10% difference between observed and expected fracture predictions (29) . Statistical analyses were performed with Statistica software, version 10.0 (StatSoft, Tulsa, OK).
Results
Population
The final study population consisted of 58,108 women (Table 1) . Mean age (6 SD) was 64.3 6 11.1 years. BMD Z-scores indicated that measurements closely approximated the reference populations used. Osteoporosis based on femoral neck T-score was documented in 11.9% of women and when based upon the minimum T-score at any measured skeletal site was seen in 27.2% of women.
Statistically significant linear trends for most of the baseline characteristics were noted when the study Smaller (vs larger) area quintile was associated with younger age, lower prevalence of prior fracture, and lower fracture probability measurements despite lower age-adjusted BMD Z-scores. Data are expressed as mean 6 SD or number (percentage). P value is for linear trend.
population was stratified by total hip bone area quintile. Smaller (vs larger) total hip area was associated with younger age, lower prevalence of prior fracture, and lower fracture probability measurements. Conversely, BMD T-scores and Z-scores tended to be lower, prevalence of osteoporosis based on BMD T-score greater, with a slightly greater chance of receiving osteoporosis treatment. Table 2 . In addition to standard risk factors (older age, lower body mass index, prior fracture, lower BMD, and higher fracture probability), incident MOF and incident hip fracture were associated with higher total hip area and HAL.
Fractures
Number of fractures and crude incident fracture rates (per 1000 person-years) are summarized in Table 3 . Despite similar follow-up time, numbers and rates of incident MOF and hip fractures were lower in women with smaller vs larger total hip bone area (P for linear trend , 0.001). After adjustment for baseline fracture probability with BMD, a statistically significant effect of total hip bone area was again observed (P , 0.001). Compared with the middle tertile, for women with total hip area in the smallest quintile (quintile 1), there was a nonsignificantly lower risk for incident MOF (HR, 0.94; 95% CI, 0.85 to 1.03) with a significantly lower risk for incident hip fracture (HR, 0.70; 95% CI, 0.57 to 0.85). Conversely, for women with the largest total hip area (quintile 5), there was a significantly greater risk for incident MOF (HR, 1.19; 95% CI, 1.09 to 1.29) and incident hip fracture (HR, 1.32; 95% CI, 1.13 to 1.55). After further adjustment for HAL, however, there was no significant effect of total hip bone area quintile (Table 4) .
Similar results were seen when analysis was based on total hip bone area as a continuous measure (per SD increase). Model 1 (adjusted for fracture probability with BMD) showed a significantly greater risk for incident MOF (HR, 1.08; 95% CI, 1.05 to 1.11) and incident hip fracture (HR, 1.16; 95% CI, 1.11 to 1.21). This was no longer statistically significant after further adjustment for HAL (model 2). In contrast, adjustment for current height rather than HAL did not remove the effect of total hip area (data not shown).
The maximum effect was seen when quintile 1 was used as the referent (Supplemental Table 1 ); for women with the largest total hip area (quintile 5), there was increased risk for incident MOF (HR, 1.27; 95% CI, 1.16 to 1.39) and even greater risk for incident hip fracture (HR, 1.90; 95% CI, 1.58 to 2.27). Nonhip MOFs were also affected by total hip area (HR, 1.17; 95% CI, 1.06 to 1.30, quintile 5 vs quintile 1), although the effect was weaker than when analyses included hip fractures and was no longer significant after adjustment for HAL (HR, 1.07; 95% CI, 0.95 to 1.21). Similar patterns, but a smaller effect size, were seen for total hip bone area when fracture probability was computed without BMD (Supplemental Table 2 ). Femoral neck BMD and fracture probability predicted incident MOF with similar HRs when stratified by total hip area quintiles (all P interaction . 0.1; Supplemental Table 3 ). In contrast, prediction of incident hip fracture was slightly weaker (although still significant) in patients with larger total hip area (all P interaction , 0.05; Supplemental Table 3 ).
Effect on FRAX ® calibration Calibration ratios (observed vs predicted 10-year fracture probability) were estimated for incident MOF and incident hip fracture (Fig. 1 ). There was a positive association between increasing total hip area quintile and the calibration ratio when predicted fracture probability was estimated with BMD, but this was not seen when fracture risk was estimated without BMD. Fracture probability without BMD was well calibrated across all hip area quintiles; fracture probability with BMD underestimated MOF risk in the largest hip area quintile (calibration ratio quintile 5, 1.12) and underestimated HF risk in the three largest hip area quintiles (calibration ratios quintile 3, 1.21; quintile 4, 1.30; quintile 5, 1.44).
Discussion
This large registry-based study confirmed previous reports regarding the importance of bone area on areal BMD measurements and diagnosis of osteoporosis. It Data are from Cox proportional hazards models, with the middle tertile as the referent. There was a significant linear trend (increasing MOF and hip fracture risk with larger total hip bone area quintile) when adjusted for fracture probability (model 1) but not after adjustment for both fracture probability and HAL (model 2). Similar results were seen when analysis was based on total hip bone area as a continuous measure (per SD increase). Boldface font indicates P , 0.05.
further extends this to the effect of bone area on fracture probability estimated by using the FRAX ® tool. The effect was significant for fracture probability calculated with femoral neck BMD but, as hypothesized, was much weaker when fracture probability estimated without BMD. The degree of miscalibration in FRAX ® with BMD was most evident in women with total hip bone area in the largest quintiles, where observed 10-year fracture probability was significantly greater than predicted fracture probability. In contrast, fracture probability was slightly overestimated among women with smaller total hip bone area. Adjusting for HAL [an established BMD-and FRAX ® -independent risk factor for osteoporotic hip fracture (14-16)] seemed to entirely negate the effects of total hip bone area that we identified. Therefore, the current report provides both the observation and a potential solution for the effect of bone area, complementing our previous work which did not examine the confounding effect of bone area (14, 15) . The current report reflects examination of the effect of skeletal size on the performance of FRAX ® . Although the degree of FRAX ® miscalibration may appear to be relatively small (observed/predicted ratio: 1.12 for MOF and 1.44 for hip fracture in the largest quintile), this could substantially affect osteoporosis treatment decision making. Further studies have shown that miscalibration as small as 10% can affect treatment decision making; for women, a 1% change in MOF calibration resulted in a 2.5% change in intervention rates (and this was even greater for men) (29) .
Limitations to this analysis are acknowledged. The clinical source of the study cohort is recognized, and referred individuals may be at higher perceived risk; however, mean Z-scores were close to zero, suggesting little bias in terms of BMD. Furthermore, because we included all individuals within the geographic region referred for BMD testing, our results are likely to be broadly generalizable to clinical practice. Only a single scanner configuration and software implementation were studied. Whether similar results would be seen with other manufacturers or scanners is unclear. Because HAL is a simple length measurement, it would likely show high levels of agreement across scanners. HAL may be useful for initial fracture risk assessment, but because this parameter is not amenable to fracture prevention treatment, it is unlikely to be useful for serial assessment. This measure may also be affected by osteoarthritis of the hip, which limits the ability of the subject to achieve optimal internal rotation of the hip for profiling of the proximal femur; this may explain the small positive association between age and HAL (30, 31) . For our study population, we intentionally excluded men and nonwhite women to avoid confounding in the assessment of the effect of bone area (7, 32, 33) , and further studies are needed to see whether our findings might generalize to other groups.
In conclusion, in a large cohort of Canadian white women, we found that skeletal size affects fracture prediction based on fracture probability with BMD, with fracture risk underestimated in those with a larger hip area. Including HAL in the risk assessment compensates for this confounding by skeletal size and allows more accurate assessment of fracture risk. This adds to the evidence suggesting that HAL may be of clinical value in refining hip fracture risk and better identifying those in whom osteoporosis treatment should be considered. 
